Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Reddy

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 6, 2014
HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular diseaseC Morgantini, D Meriwether, S Baldi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 17, 2001
Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipidsS T Reddy, D J Wadleigh, V Grijalva, et al.
Journal of Lipid Research|September 7, 2000
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3M Navab, S Y Hama, G M Anantharamaiah, et al.
Atherosclerosis|June 11, 2018
Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritisC Charles-Schoeman, G B Gugiu, H Ge, et al.
Journal of Lipid Research|September 7, 2000
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1M Navab, S Y Hama, C J Cooke, et al.
Cell Death and Differentiation|March 24, 2012
PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell deathE-M Schweikert, A Devarajan, I Witte, et al.
Metabolism: Clinical and Experimental|September 12, 2021
ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIVM Daskou, M Sharma, W Mu, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 6, 2014
HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular diseaseC Morgantini, D Meriwether, S Baldi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 17, 2001
Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipidsS T Reddy, D J Wadleigh, V Grijalva, et al.
Journal of Lipid Research|September 7, 2000
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3M Navab, S Y Hama, G M Anantharamaiah, et al.
Atherosclerosis|June 11, 2018
Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritisC Charles-Schoeman, G B Gugiu, H Ge, et al.
Journal of Lipid Research|September 7, 2000
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1M Navab, S Y Hama, C J Cooke, et al.
Cell Death and Differentiation|March 24, 2012
PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell deathE-M Schweikert, A Devarajan, I Witte, et al.
Metabolism: Clinical and Experimental|September 12, 2021
ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIVM Daskou, M Sharma, W Mu, et al.
Pageof 5